StudyRareStudyRare
Log in to add personal notes on this page.

A 30-year-old man has difficulty releasing his grip after a handshake. He has frontal balding, bilateral ptosis, and cataracts. His mother and grandmother are also affected.

AD; CTG repeat expansion in the 3' UTR of DMPK (myotonin-protein kinase); the expanded transcript is thought to disrupt alternative splicing

  • Normal: 5-34 repeats
  • Mutable normal (premutation): 35-49 (no symptoms, but may expand in offspring)
  • Mild: 50-150
  • Classic: 100-1,000
  • Congenital: >1,000
  • The phenotype ranges overlap, and repeat size varies between tissues

Myotonin-protein kinase is a serine-threonine kinase located at structures in heart and skeletal muscle tied to conduction and impulse transmission. DM1 has one mutational mechanism: the CTG repeat in the 3' UTR expands past 49 repeats. No other variant type in DMPK causes it. Because the repeat sits outside the coding sequence, its effect is thought to work through the RNA: a set of splicing events governed by two antagonistic CUG-binding proteins, CUG-BP and MBNL1 (muscleblind), is disrupted, and embryonic splice forms predominate in adult tissue. Each mis-spliced message maps to a feature:

  • Chloride channel → myotonia
  • Insulin receptor → diabetes risk
  • Tau (MAPT) → cognitive involvement

The repeat is unstable in body cells as well as in meiosis. Repeat size differs between organs, which partly explains the wide variability and why a blood measurement predicts severity imperfectly. Alleles above 34 repeats can expand in meiosis, giving anticipation, and congenital DM1 is most often inherited from the mother. Interruptions such as CCG or CGG within the repeat (3% to 8% of expansions) may give later onset and milder disease.

  • Myotonia (delayed muscle relaxation)
  • Progressive muscle weakness (distal > proximal)
  • Facial weakness ("hatchet face"), ptosis
  • Cataracts (posterior subcapsular)
  • Cardiac conduction defects
  • Cognitive/behavioral
  • Insulin resistance, testicular atrophy

Congenital DM1: Maternal transmission, severe hypotonia, respiratory failure, intellectual disability

Anticipation: Striking - especially maternal (congenital form)

  • Clinical clues: grip and percussion myotonia, distal weakness, frontal balding, ptosis, and posterior subcapsular cataracts
  • Targeted testing for the CTG repeat expansion in DMPK (standard PCR plus Southern blot or triplet-repeat-primed PCR for large alleles; see Repeat expansion testing)
  • EMG shows myotonic discharges, but molecular testing is confirmatory
  • Larger repeats correlate with earlier onset and severity; counsel on anticipation and the maternally transmitted congenital form
  • Annual ECG/cardiology surveillance for conduction block and arrhythmia; pacemaker/ICD when indicated (a leading cause of death)
  • Pulmonary monitoring and treatment of respiratory weakness and sleep-disordered breathing
  • Mexiletine for symptomatic myotonia; periodic cataract and diabetes screening
  • Anesthesia precautions: high risk of respiratory and cardiac complications; avoid depolarizing agents and minimize opioids/sedatives

"MyoToniC = CTG": The trinucleotide repeat (CTG) is embedded in the name. Cataracts / Cheek wasting / Cardiac arrhythmia, Toupee (early balding in men), Gonadal atrophy.

"MyoToxic dystrophy": CTG expansion in 3' UTR of DMPK produces toxic mRNA.

"Myotonic dUsTRophy" (UTR): The CTG repeat sits in the 3' UTR of DMPK.

"Examine the Mother in Myotonic": Congenital DM1 is almost always maternally transmitted, so examine the mother for signs of disease. (Non-congenital DM1 expansions are frequently transmitted by either parent.)

"MeTrONome in MyoTONic": Cardiac conduction defects and arrhythmias are the #2 cause of death (#1 is respiratory failure).